__NUXT_JSONP__("/drugs/Vatalanib_Succinate", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"212142-18-2",chebiId:"",chemicalFormula:"C20H15ClN4.C4H6O4",definition:"The succinate salt of vatalanib, an anilinophthalazine derivative, with antineoplastic activity.  Vatalanib binds to and inhibits the protein kinase domain of vascular endothelial growth factor receptors 1 and 2; both receptor tyrosine kinases are involved in angiogenesis.  This agent also binds to and inhibits related receptor tyrosine kinases, including platelet-derived growth factor (PDGF) receptor, c-Kit, and c-Fms.",fdaUniiCode:"V5FUB77031",identifier:"C74945",preferredName:b,semanticType:"Organic Chemical",subclassOf:["C1742","C1967"],synonyms:["1-[4-Chloroanilino]-4-[4-pyridylmethyl]phthalazine Succinate","Butanedioic Acid, Compd. with N-(4-Chlorophenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine (1:1)","CGP 79787D","PTK 787","PTK-787","PTK787","VATALANIB SUCCINATE",b,"ZK 222584"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FVatalanib_Succinate",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Vatalanib_Succinate","Vatalanib Succinate","2021-10-30T13:44:28.883Z")));